EA201291175A1 - Способы, относящиеся к аттенуированной микоплазме - Google Patents

Способы, относящиеся к аттенуированной микоплазме

Info

Publication number
EA201291175A1
EA201291175A1 EA201291175A EA201291175A EA201291175A1 EA 201291175 A1 EA201291175 A1 EA 201291175A1 EA 201291175 A EA201291175 A EA 201291175A EA 201291175 A EA201291175 A EA 201291175A EA 201291175 A1 EA201291175 A1 EA 201291175A1
Authority
EA
Eurasian Patent Office
Prior art keywords
attenuated
mycoplasm
methods relating
bacterium
mycoplasma
Prior art date
Application number
EA201291175A
Other languages
English (en)
Inventor
Рима Юиль
Юссеф Абс Эль-Оста
Original Assignee
Байопропертис Пти Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010902198A external-priority patent/AU2010902198A0/en
Application filed by Байопропертис Пти Лтд. filed Critical Байопропертис Пти Лтд.
Publication of EA201291175A1 publication Critical patent/EA201291175A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

В изобретении предложен способ идентификации или получения аттенуированной бактерии Mycoplasmaкоторая содержит мутацию по меньшей мере в одном из перечисленных генов, и применение бактерии в вакцине для индукции защитного иммунитета против Mycoplasmaили для обнаружения инфицирования указанной бактерией.
EA201291175A 2010-05-19 2011-05-19 Способы, относящиеся к аттенуированной микоплазме EA201291175A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2010902198A AU2010902198A0 (en) 2010-05-19 Methods relating to an attenuated mycoplasma
PCT/AU2011/000584 WO2011143706A1 (en) 2010-05-19 2011-05-19 Methods relating to an attenuated mycoplasma

Publications (1)

Publication Number Publication Date
EA201291175A1 true EA201291175A1 (ru) 2013-06-28

Family

ID=44991084

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201291175A EA201291175A1 (ru) 2010-05-19 2011-05-19 Способы, относящиеся к аттенуированной микоплазме

Country Status (11)

Country Link
US (1) US9260691B2 (ru)
EP (1) EP2571980A4 (ru)
JP (1) JP2013526866A (ru)
KR (1) KR20130086154A (ru)
CN (1) CN102985530A (ru)
AU (1) AU2011256137B2 (ru)
BR (1) BR112012029396A2 (ru)
CA (1) CA2799732A1 (ru)
EA (1) EA201291175A1 (ru)
MX (1) MX2012013409A (ru)
WO (1) WO2011143706A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2684959A1 (en) * 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
CN114940955B (zh) * 2022-05-10 2023-08-11 兆丰华生物科技(南京)有限公司 一种鸡毒支原体弱毒疫苗株及其应用
CN117690485B (zh) * 2024-02-04 2024-05-28 北京诺禾致源科技股份有限公司 用于寄生虫鉴定的基因组的处理方法和处理装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914160A (pt) 1998-09-30 2001-06-26 American Cyanamid Co Composição antigênica, método para aumentar a capacidade de uma composição antigênica que contenha um antìgeno selecionado de uma bactéria, vìrus, fungo ou parasita patogênicos, do haemophilus influenzae, do helicobacter pylori, do vìrus sincicial respiratório, do rotavìrus, e, do vìrus simples do herpes para evocar a resposta imune de um hospedeiro vertebrado, plasmìdeo, célula hospedeira, método para produzir uma holotoxina do cólera mutante imunogênica, e, uso de uma quantidade auxiliar eficaz de uma holotoxina do cólera mutante
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
BRPI0710550A2 (pt) * 2006-04-10 2011-08-16 Intervet Int Bv uso de uma dose imunogênica de material imunogênico de mycoplasma hyopneumoniae e uma dose imunogênica de vìrus de prrs atenuado vivo, kit de vacina, e, método para a vacinação de porcos
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
CL2008002675A1 (es) * 2007-09-11 2008-11-07 Wyeth Corp Bacteria de mycoplasma gallisepticum atenuada; composicion de vacuna que la comprende; método de vacunación; y método de identificación de clones de mycoplasma gallisepticum atenuados.
RU2489164C9 (ru) * 2007-11-06 2014-01-20 ВАЙЕТ ЭлЭлСи АВИРУЛЕНТНАЯ АДЪЮВАНТНАЯ ЖИВАЯ ВАКЦИНА ПРОТИВ Mycoplasma hyopneumoniae
MX2011007606A (es) * 2009-02-20 2011-08-08 Australian Poultry Crc Pty Ltd Vacunas atenuadas vivas.
EP2453913B1 (en) * 2009-05-19 2016-06-22 Bioproperties Pty Ltd A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof

Also Published As

Publication number Publication date
AU2011256137A1 (en) 2012-11-29
CA2799732A1 (en) 2011-11-24
JP2013526866A (ja) 2013-06-27
BR112012029396A2 (pt) 2019-09-24
EP2571980A1 (en) 2013-03-27
EP2571980A4 (en) 2014-02-26
MX2012013409A (es) 2013-03-07
AU2011256137B2 (en) 2015-01-22
US9260691B2 (en) 2016-02-16
WO2011143706A1 (en) 2011-11-24
KR20130086154A (ko) 2013-07-31
US20130243819A1 (en) 2013-09-19
CN102985530A (zh) 2013-03-20

Similar Documents

Publication Publication Date Title
BR112014033046A2 (pt) linhagem mutante atenuada de salmonella typhi, vacina de dna e vacina de dna vxm01
UY34218A (es) MÉTODO DE DETECCIÓN DEL EVENTO DE SOJA pDAB9582.814.19.1
CL2015001054A1 (es) Métodos de cultivo de microorganismos en condiciones mixotrópicas no axénicas.
EA201291157A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
BR112014030257A2 (pt) arranjo de fonte sísmica, e método de avaliação sísmica.
BR112013027378A2 (pt) nó b evoluído, equipamento de usuário, método implementado por computador e dispositivo de equipamento de usuário
MY173796A (en) Attenuated streptococcus suis vaccines and methods of making and use thereof
PH12015501101B1 (en) Method for eliciting an immune response to an immunogen
GB2518813A (en) OMV vaccine against Burkholderia infections
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
MX2010000864A (es) Vacuna de celulas enteras estafilococcicas inactivadas.
EA201790517A1 (ru) Способы и композиции для индуцирования защитного иммунитета против филовирусной инфекции
MX2014000920A (es) Metodo para evaluar la integridad de la pared celular bacteriana.
EA201190311A1 (ru) Температурочувствительный вакцинный штамм mycoplasma hyopneumoniae и его применения
EA201690075A1 (ru) Способ лечения внутриклеточной инфекции
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
CY1123049T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους
EA201291175A1 (ru) Способы, относящиеся к аттенуированной микоплазме
TN2015000020A1 (en) Molecular markers and methods for early sex determination in date palms
MX2014015766A (es) Receptores de tipo toll y oligonucleotidos inmunoestimuladores.
MX2015010776A (es) Metodos y composiciones para detectar y tratar mutantes de akt resistentes a farmacos.
MX371126B (es) Vacuna para cerdos contra el sindrome reproductivo y respiratorio porcino y lawsonia intracellularis.
GB2515222A (en) Use of flagellin as a vaccine
IT1402546B1 (it) Apparecchi, sistema e procedimento per indumenti protettivi